Early Cervical Cancer Detection Is Now as Easy as a Urine Test

Dear Sahabat PRAMITA,

Cervical cancer is one of the most common types of cancer affecting Indonesian women. Ranking second after breast cancer, it is often diagnosed at an advanced stage due to the absence of early symptoms. In fact, over 90% of cervical cancer cases are caused by HPV (Human Papillomavirus) infection, which is detectable early.

Now, screening is easier than ever. The HPV DNA urine test offers a practical, comfortable, and non-invasive option. No need for cervical sampling—just collect your first morning urine. Cervical cells naturally shed into the urine can reveal the presence of high-risk HPV.

Benefits of this test include:

No fasting required

Non-invasive and painless

Can be done independently

Comfortable and practical

Accurate in detecting high-risk HPV

This test is especially recommended for women with abnormal Pap smear results, those who are sexually active, or those with risk factors such as smoking, poor intimate hygiene, or family history of cervical cancer.

Preparation Guidelines:
No sexual activity 24 hours before the test

Ensure clean and dry genital area

Avoid testing during urinary tract infection

Consult your doctor if pregnant

WHO also recommends HPV screening as a key strategy in eliminating cervical cancer globally. With PRAMITA, protect yourself early—because prevention starts with detection.